| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 150 points on Tuesday.
The Dow traded up 0.46% to 37,476.21 while the NASDAQ rose 0.41% to 14,966.74. The S&P 500 also rose, gaining, 0.38% to 4,758.55.
Check This Out: Cisco Systems, Electronic Arts And 2 Other Stocks Insiders Are Selling
Materials shares rose by 1% on Tuesday.
In trading on Tuesday, information technology shares fell by 0.1%.
Shares of FactSet Research Systems Inc (NYSE:FDS) gained on Tuesday after the company reported earnings results for its first quarter.
FactSet Research reported quarterly sales growth of 7.4% Y/Y to $542.2 million, marginally beating the consensus of $540.36 million. Adjusted EPS of $4.12 beat the consensus of $4.11.
FactSet lowered FY24 revenue outlook to $2.20 billion-$2.21 billion (from $2.21 billion-$2.23 billion) vs. $2.22 billion estimate and adj. EPS to $15.60-$16.00 (from $15.65-$16.15) vs. consensus of $16.08.
Compugen Ltd. (NASDAQ:CGEN) shares shot up 159% to $1.8901 after Gilead announced an agreement with the company to exclusively license its novel pre-clinical immunotherapy program.
Shares of Intelligent Bio Solutions Inc. (NASDAQ:INBS) got a boost, surging 57% to $0.4391. Intelligent Bio Solutions received National Association of Testing Authorities accreditation for its Intelligent Fingerprinting Drug Screening Solution.
Infobird Co., Ltd (NASDAQ:IFBD) shares were also up, gaining 23% to $1.66 after the company inked a new business cooperation in software development of information technology system.
Motus GI Holdings, Inc. (NASDAQ:MOTS) shares dropped 45% to $1.18 after the company priced its $5 million public offering.
Shares of BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) were down 44% to $0.3849 after the company reported pricing of $1.5 million registered direct offering.
Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) was down, falling 20% to $2.43 after the company disclosed the pricing of $5.2 million underwritten public offering.
Also Check This Out: How To Earn $500 A Month From General Mills Stock Ahead of Quarterly Earnings Report
In commodity news, oil traded up 0.8% to $73.08 while gold traded up 0.7% at $2,055.30.
Silver traded up 1.2% to $24.40 on Tuesday while copper rose 1.9% to $3.9245.
European shares were mostly higher today. The eurozone’s STOXX 600 gained 0.28%, London’s FTSE 100 gained 0.16% while Spain’s IBEX 35 Index rose 0.29% The German DAX rose 0.44% French CAC 40 rose 0.02%, while Italy’s FTSE MIB Index rose 0.23%.
Annual inflation rate in the Eurozone eased to 2.4% in November from 2.9% in the previous month.
Asia Pacific Markets
Asian markets closed mostly higher on Tuesday, with Japan’s Nikkei 225 gaining 1.41%, Hong Kong’s Hang Seng Index declining 0.75% and China’s Shanghai Composite Index gaining 0.05%. India’s S&P BSE Sensex, meanwhile, rose 0.17%.
Hong Kong’s unemployment rate came in unchanged at 2.9% for the three months ending Nov. 2023. The Bank of Japan held its key short-term interest rate at -0.1% during its latest meeting.
Building permits in the U.S. declined by 2.5% to an annual rate of 1.460 million in November, down from market estimates of 1.470 million.
U.S. housing starts surged 14.8% month-over-month to an annualized 1.56 million in November, compared to market estimates of 1.36 million.
Now Read This: Top 5 Financial Stocks That May Keep You Up At Night In December
